Cargando…

Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland

The main goal of this study was to draw the attention of physicians to commonly undisclosed risk of breast cancer (BrCa) in women suffering from neurofibromatosis type 1 (NF-1), which is 5-fold higher than in the general population. NF-1 related BrCa arises earlier (< 50 years) and is more advanc...

Descripción completa

Detalles Bibliográficos
Autor principal: Karwacki, Marek W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403769/
https://www.ncbi.nlm.nih.gov/pubmed/32774141
http://dx.doi.org/10.5114/wo.2020.97637
_version_ 1783567006165893120
author Karwacki, Marek W.
author_facet Karwacki, Marek W.
author_sort Karwacki, Marek W.
collection PubMed
description The main goal of this study was to draw the attention of physicians to commonly undisclosed risk of breast cancer (BrCa) in women suffering from neurofibromatosis type 1 (NF-1), which is 5-fold higher than in the general population. NF-1 related BrCa arises earlier (< 50 years) and is more advanced, with an increased mortality. NF-1 is one of the most frequent monogenic diseases worldwide and a tumor predisposition syndrome. The Nf1 gene is an important negative regulator of the Ras oncogene and belongs to the family of the 12 the most important BrCa predisposition genes. Planning introduction of BrCa screening guidelines for NF-1 women in Poland we started with assessment of BrCa risk awareness and current preventive practices in this population by a survey published in an open access internet profile dedicated exclusively to patients with NF-1 in Poland, with 1928 participants. As a result, we revealed that the awareness of this specific risk was declared by only 30% out of 138 responders, and only 21% of them received this information from medical professionals. In all 4 (2.89%) women suffering from BrCa the cancer was diagnosed before the 50(th) year of age. It exceeds significantly the expected prevalence of BrCa in the general population of Polish women. We conclude that the limited awareness of NF-1 related BrCa risk in Polish patients warrants the educational effort directed both to the NF-1 patients by professional counseling and to the medical community, in order to increase the efficacy of preventive measures and decrease BrCa mortality.
format Online
Article
Text
id pubmed-7403769
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-74037692020-08-07 Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland Karwacki, Marek W. Contemp Oncol (Pozn) Short Communication The main goal of this study was to draw the attention of physicians to commonly undisclosed risk of breast cancer (BrCa) in women suffering from neurofibromatosis type 1 (NF-1), which is 5-fold higher than in the general population. NF-1 related BrCa arises earlier (< 50 years) and is more advanced, with an increased mortality. NF-1 is one of the most frequent monogenic diseases worldwide and a tumor predisposition syndrome. The Nf1 gene is an important negative regulator of the Ras oncogene and belongs to the family of the 12 the most important BrCa predisposition genes. Planning introduction of BrCa screening guidelines for NF-1 women in Poland we started with assessment of BrCa risk awareness and current preventive practices in this population by a survey published in an open access internet profile dedicated exclusively to patients with NF-1 in Poland, with 1928 participants. As a result, we revealed that the awareness of this specific risk was declared by only 30% out of 138 responders, and only 21% of them received this information from medical professionals. In all 4 (2.89%) women suffering from BrCa the cancer was diagnosed before the 50(th) year of age. It exceeds significantly the expected prevalence of BrCa in the general population of Polish women. We conclude that the limited awareness of NF-1 related BrCa risk in Polish patients warrants the educational effort directed both to the NF-1 patients by professional counseling and to the medical community, in order to increase the efficacy of preventive measures and decrease BrCa mortality. Termedia Publishing House 2020-07-03 2020 /pmc/articles/PMC7403769/ /pubmed/32774141 http://dx.doi.org/10.5114/wo.2020.97637 Text en Copyright © 2020 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Short Communication
Karwacki, Marek W.
Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
title Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
title_full Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
title_fullStr Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
title_full_unstemmed Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
title_short Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
title_sort breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in poland
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403769/
https://www.ncbi.nlm.nih.gov/pubmed/32774141
http://dx.doi.org/10.5114/wo.2020.97637
work_keys_str_mv AT karwackimarekw breastcancerriskunawarenessamongwomensufferingfromneurofibromatosistype1inpoland